期刊文献+

下调miR-886-5p的表达对宫颈癌SiHa细胞增殖的影响 被引量:1

EFFECT OF MIR-886-5P KNOCKDOWN ON PROLIFERATION IN SIHA CELLS
原文传递
导出
摘要 目的探讨下调miR-886-5p的表达对SiHa细胞增殖的影响。方法应用脂质体转染法分别将miR-886-5p表达抑制质粒及其对照质粒转染SiHa细胞,经Blasticidin抗生素筛选,得到稳定抑制miR-886-5p表达的SiHa细胞(SiHa miR-886-5p inhibitor)和稳定转染对照质粒的细胞;RT-PCR进行验证;采用MTT测增殖及克隆形成实验检测细胞的增殖能力。结果获得了稳定抑制miR-886-5p表达的宫颈癌SiHa细胞系;MTT测增殖实验发现,SiHa miR-886-5p inhibitor体外增殖能力比SiHa miR-886-5p NC及未转染质粒组细胞均明显减弱(P<0.05);克隆形成实验发现,SiHa miR-886-5p inhibitor体外克隆形成能力比SiHa miR-886-5p NC及未转染质粒组细胞均明显减弱(P<0.01)。结论下调miR-886-5p可显著抑制SiHa细胞的增殖,提示靶向抑制miR-886-5p为宫颈癌的治疗提供了新思路。 Objective To investigate the effects of miR- 886 - 5p knockdown on proliferation in SiHa cells. Methods SiHa cells were transfected with miR- 886 - 5p knockdown plasmid and negative control plasmid. After selected with Blasticidin, stable miR- 886 - 5p knockdown (SiHa miR- 886 - 5p inhibitor) and negative control clones (SiHa miR- 886 - 5p NC) were obtained, and then a qRT - PCR was used to examine the transfection efficiency of cells. Furthermore, MTT for proliferation and colony formation assay were used to examine the effect of miR- 886 - 5p to SiHa cells. Results The miR - 886 - 5p knockdown cell lines of cervical cancer were obtained, and results showed that proliferation ability of SiHa miR- 886 - 5p inhibitor was weaker than SiHa miR- 886 - 5p NC and SiHa untransfected by means of MTT methods (P〈0.05) and colony formation assay (P〈0.01). Conclusion The miR- 886 - 5p knockdown can signif- icantly suppress the celluar proliferation in SiHa cells. It provides a new idea for the treatment of cervical cancer by inhibiting miR - 886 - 5p.
出处 《中国煤炭工业医学杂志》 2014年第9期1489-1492,共4页 Chinese Journal of Coal Industry Medicine
基金 河北省秦皇岛市科技支撑计划项目(编号:2012023A114)
关键词 宫颈癌 miR-886—5p SIHA细胞 克隆形成 Cervical cancer MiR- 886 - 5p SiHa cell Clone formation
  • 相关文献

参考文献10

  • 1Lu J, Getz G, Miska EA, et al. MicroRNAs expres- sion profiles classify human cancers [J]. Nature, 2005,435:834 - 838.
  • 2Esquela- Kerscher A, Slack FJ. Oncomirs- microR- NAs with a role in cancer[J-]. Nat Rev Cancer,2006, 6 :259 - 269.
  • 3Thomison Ill J, Thomas LK, Shroyer KR. Human pa- pillomavirus: molecular and cytologic/histologic as- pects related to cervical intraepithelial neoplasia and carcinoma[J]. Hum Pathol,2008,39 : 154 - 166.
  • 4Yao Q,Xu H,Zhang QQ,et al. MicroRNA - 21 pro- motes cell proliferation and down- regulates the ex- pression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells [J]. Biochem Biophys Res Commun, 2009,388 : 539 - 542.
  • 5Wang X,Tang S, Le SY, et al. Aberrant expression of oncogenic and tumor- suppressive microRNAs in cervical cancer is required for cancer cell growth[J]. PLoS ONE, 2008,3 : e2557.
  • 6Lee JW, Choi CH, Choi J J, et al. Altered microRNA expression in cervical carcinomas [J]. Clin Cancer Res, 2008,14 : 2535 - 2342.
  • 7Li JH,Xiao Xue,Zhang YN, et al. MicroRNA miR - 886- 5p inhibits apoptosis by down regulating Bax expression in human cervical carcinoma eells[J]. Gynecologic Oneology,2011, 120 : 145 - 151.
  • 8Livak KJ, Sehmittgen TD. Analysis of relative gene expression data using real - time quantitative PCR and the 2(- Delta Delta C (T)) method[J]. Methods,2001,25:402 - 408.
  • 9张帅,武雅琴,冯冬杰,张治,蒋峰,尹荣,许林.miR-145通过下调OCT4基因抑制肺腺癌干细胞增殖[J].中国肺癌杂志,2011,14(4):317-322. 被引量:20
  • 10Arndt GM, Ossey L, Cullen LM, et al. Characterization of global microRNA expression reveals oncogen- ic potential of miR- 145 in metastatic colorectal cancer[J]. BMC Cancer,2009 , 9(374) : 1 - 17.

二级参考文献13

  • 1Tysnes BB. Tumor-initiating and -propagating cells: cells that we would like to identify and control. Neoplasia, 2010, 12(7): 506-515.
  • 2Bertolini G, Roz L, Perego P, et al. Fiighly tumorigenic lung cancer CD133^+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA, 2009, 106(38): 16281-16286.
  • 3Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact.J Clin Oncol, 2009, 27(34): 5848-5856.
  • 4Sun Y, Bai Y, Zhang F, et al. miR- 126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7. Biochem Biophys Res Commun, 2010, 391(1): 1483-1489.
  • 5Rogler CE, Levoci L, Ader T, et al. MicroRNA-23b cluster microRNAs regu- late transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology, 2009, 50(2): 575-584.
  • 6Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative Ct method. Nat Protoc, 2008, 3(6): 1101-1108.
  • 7Hammond SM. RNAi, microRNAs, and human disease. Cancer Chemother Pharmacol, 2006, 58 (Suppl 1): 63-68.
  • 8Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 2006, 9(3): 189-198.
  • 9Sachdeva M, Mo YY. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res, 2010, 70(1): 378-387.
  • 10Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126(4): 663-676.

共引文献19

同被引文献16

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部